HCA will purchase the stock at a price of $18.61 per share, totaling about $1.5 billion, and the transaction is expected to be finalized on Sept. 21. The three Bank of America designees on HCA’s board of directors will also step down, the release said.
Bank of America recently announced it would eliminate 30,000 jobs over the next few years, and the bank is looking to sell assets to raise capital, according to a Bloomberg report.
Related Articles on HCA:
HCA: Decline in Heart Surgeries Led to Low 2Q Postings
HCA, Adventist Health Opening Two Hospitals in Florida
HCA Net Income Down 22%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
